start epr3 tutorial

Begin the Tutorial

ASTHMA IQ EPR-3 Asthma Guidelines Module

Programmed by the AAAAI. Funded though an educational grant from Genentech/Novartis.

Accreditation Statement:
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement:
The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum number of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CE Designation Statement
The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 1.80 Contact Hours.

AAAAI Privacy Policy:
To verify your participation in live educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org.

Target Audience:
Allergist/immunologists and other asthma specialists, A/I Fellows in Training (FITs), allied health professionals

Medium and Method of Physician Participation:
This is an online enduring material. To complete this activity:

  1. Review the target audience, learning objectives and author disclosures
  2. Study the power point presentation
  3. Complete the post test and activity evaluation

Learning Objectives:
Upon completion of this activity, participants will be able to:

  1. Explain the pediatric and adult implications of the new asthma guidelines.
  2. Describe the difference between severity and control assessments and determine when it is appropriate to use each assessment.
  3. Determine appropriate pharmacological treatment regimens for their patients with asthma utilizing the stepwise approach.

AAAAI Disclosure Policy:
Please click here to review the AAAAI Disclosure Policy.

Planning Committee:
(AAAAI personnel)
Stuart Abramson, MD, PhD, FAAAAI
Thomas B. Casale, MD, FAAAAI
Stanley Goldstein, MD, FAAAAI
James T. Li, MD, PhD, FAAAAI
Michael Schatz, MD, MS, FAAAAI
Stanley Szefler, MD, FAAAAI
Richard Wasserman, MD, PhD, FAAAAI

Planning Committee Members disclosed no relevant financial relationships.

Faculty Disclosures
(AAAAI personnel)
Stuart Abramson, MD, PhD, FAAAAI - Employment: Baylor College of Medicine: Department of Pediatrics, Allergy/Immunology Section; Financial Interests: GSK, Novartis, ZLB Behring: Speaker's bureau; Research Interests: ZLB Behring, Novartis: Clinical research contract; Organizational Interests: Mothers for Clean Air, American Lung Association: Advisory board member; Greater Houston Allergy Society: President; Texas Allergy, Asthma & Immunology Society: Secretary-Treasurer

Thomas B. Casale, MD, FAAAAI - Employment: Creighton University School of Medicine: Professor of Medicine, Chief Allergy and Immunology; Financial Interests: Capnia, Inc: Consulting fees; Educational Concepts in Medicine: Honoraria; Novartis Pharmaceuticals: Honoraria, consulting fees; Gray Consulting, Inc: Consulting fees; Allux Medical, Inc: Consulting fees; Adelphi: Honoraria; Wolters Kluwer Health, Inc: Royalties; Zymo/Genetics: Honoraria; Research Interests: Pfizer, Inc: Principal investigator; Dynavax, Inc: Principal investigator; Capnia, Inc: Principal investigator; Schering-Plough: Principal investigator; Novartis Pharmaceuticals: Principal investigator; NIH: Principal/sub-investigator; Genentech: Principal investigator; Alcon: Principal investigator; Kendle: Principal investigator; Amgen: Principle investigator; ZLB: Sub-investigator; Organizational Interests: American Thoracic Society: Committee member; ABAI: Board of Directors; Respiratory and Allergic Diseases Foundation: Vice president; World Allergy Organization: Board of Directors; Joint Council for Allergy, Asthma & Immunology: Board of Directors

Stanley Goldstein, MD, FAAAAI - Employment: Allergy and Asthma Care of Long Island: Director Financial Interests: Novartis, GSK, Schering Plough, Sanofi Aventis, Merck, Genentech: Clinical research and speaker's bureau; Hoffman La-Roche, Amgen, Skye Pharma, Allergy Therapeutics, Apotex, Cobalis: Clinical research; Astra Zeneca: Speaker's bureau; Research Interests: Novartis, GSK, Schering Plough, Sanofi Aventis, Merck, Genentech, Hoffman-LaRoche, Amgen, Skye Pharma, Allergy Therapeutics, Apotex, Cobalis: Clinical research; Organizational Interests: Asthma Coalition of Long Island: Chair; NYS Asthma Guideline Expert Panel: Member

James T. Li, MD, PhD, FAAAAI - Employment: Mayo Clinic: Professor of Medicine; Organizational Interests: ABAI: Director; ACP: Guideline Writer

Michael Schatz, MD, MS, FAAAAI - Employment: Kaiser Permanente: Chief, Department of Allergy; Financial Interests: GlaxoSmithKline: Consultant to ETA Now, a non-branded initiative sponsored by GSK to improve asthma control in the US; GlaxoSmithKline: Have received honoraria for speaking on the subjects of asthma and pregnancy, asthma control, and the burden of rhinitis; Genentech: Honorarium for speaking on the subject of asthma control in large populations; Research Interests: GlaxoSmithKline: Grant support (asthma control test); Aventis: Grant support (asthma burden study using administrative data); GlaxoSmithKline: Research (rhinitis burden and asthma care management)

Stanley Szefler, MD, FAAAAI - Employment: National Jewish Medical and Research Center: Professor of Pediatrics and Pharmacology; Financial Interests: AstraZeneca, Aventis, Merck, Genentech, Novartis: Consultant; Research Interests: Ross, Division of Abbott: Clinical research grant; NHLBI: Childhood Asthma Research and Education Network; NHLBI: Asthma Clinical Research Network; NHLBI: Childhood Asthma Management Program; NHLBI: Proteomics in Pediatric Lung Disease; Colorado Cancer, cardiovascular and Pulmonary Disease Program: Grant to conduct an outreach asthma program for the Denver Public Schools; Organizational Interests: American College of Allergy, Asthma & Immunology: Fellow; American Academy of Pediatrics: Fellow; American Thoracic Society: Member; Colorado Allergy Society: Member; American Academy of Allergy, Asthma & Immunology: Fellow

Richard Wasserman, MD, PhD, FAAAAI - Employment: Dallas Allergy Immunology: President; Financial Interests: GSK, ZLB Behring: Speaker/consultant; Genentech: Speaker; GE: I am a demonstration site for GE Centricity Physician Office EMR; Research Interests: Sepracor, Novartis, Aventis, Astellas, Longwood, GSK, Medimmune, Baxter Healthcare: Investigator; Organizational Interests: Pediatric Society of Greater Dallas: Editor; Hebrew Union College: Overseer; Hobart College: Trustee, Past President, Alumni Council; Other: GE Medical Systems Information Technology: I use GE Centricity Office PM and EMR for my office information systems

Duration:

Original release date: March 14, 2008. Reviewed by faculty members Thomas B. Casale, MD FAAAAI and Michael Schatz, MD MS FAAAAI on March 14, 2010. Reviewed by Practice Improvement Chair, Dorothy Cheung, MD FAAAAI and Vice-Chair, Samuel Gubernick, DO FAAAAI on June 20, 2013. Valid for credit through March 31, 2016.

System Requirements:
ASTHMA IQ requires Adobe® Flash Player® 9. When you launch the application, you may be asked to install or upgrade Flash Player.

If you are using a web browser other than Internet Explorer, please be sure to close your web browser windows when installing or upgrading Flash Player (you should be directed back to the ASTHMA IQ website when the install is finished). If you have trouble installing Flash Player or using ASTHMA IQ, please contact the AAAAI at ASTHMA-IQ@aaaai.org.

Questions:
Activity-related questions should be directed to ASTHMA-IQ@aaaai.org.


Back